Intco Medical Technology Co., Ltd. (SHE:300677)
China · Delayed Price · Currency is CNY 39.35
-0.73 (-1.82%)
Feb 13, 2026, 3:04 PM CST
Intco Medical Technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 9,762 | 9,436 | 6,887 | 6,591 | 16,217 | 13,833 |
Other Revenue | 87.33 | 87.33 | 31.36 | 23.21 | 23.28 | 3.42 |
| 9,850 | 9,523 | 6,919 | 6,614 | 16,240 | 13,837 | |
Revenue Growth (YoY) | 9.74% | 37.65% | 4.61% | -59.27% | 17.37% | 564.29% |
Cost of Revenue | 7,506 | 7,347 | 5,976 | 5,776 | 6,267 | 4,292 |
Gross Profit | 2,343 | 2,176 | 942.35 | 837.65 | 9,973 | 9,545 |
Selling, General & Admin | 915.97 | 806.58 | 738.31 | 614.49 | 929.36 | 567.88 |
Research & Development | 414.5 | 398.34 | 283.37 | 252.32 | 365.22 | 293.3 |
Other Operating Expenses | 118.25 | 61.81 | 67.29 | 55.39 | 44.07 | 56.04 |
Operating Expenses | 1,440 | 1,291 | 1,105 | 907.94 | 1,390 | 927.47 |
Operating Income | 903.34 | 885.29 | -162.49 | -70.28 | 8,583 | 8,618 |
Interest Expense | -405.16 | -308.04 | -127.74 | -28.46 | -17.61 | -265.41 |
Interest & Investment Income | 670.16 | 596.53 | 396.16 | 193.48 | 172.61 | 4.71 |
Currency Exchange Gain (Loss) | 225.49 | 225.49 | 133.39 | 548.96 | -103.86 | - |
Other Non Operating Income (Expenses) | -21.65 | -23.13 | -16.42 | -8.61 | -10.45 | -31.97 |
EBT Excluding Unusual Items | 1,372 | 1,376 | 222.9 | 635.09 | 8,624 | 8,325 |
Gain (Loss) on Sale of Investments | 492.71 | 279.77 | 175.57 | 59.67 | 32.66 | 3.18 |
Gain (Loss) on Sale of Assets | 0.48 | 0.22 | 0.21 | 2.37 | 0.38 | 0.02 |
Asset Writedown | -77.21 | -88.8 | -21.32 | -26.87 | -29.04 | -2.08 |
Other Unusual Items | 101.42 | 41.59 | 65.46 | 34.15 | 21.07 | 20.51 |
Pretax Income | 1,890 | 1,609 | 442.82 | 704.41 | 8,649 | 8,347 |
Income Tax Expense | 146.06 | 117.23 | 54.75 | 65.07 | 1,185 | 1,342 |
Earnings From Continuing Operations | 1,744 | 1,492 | 388.06 | 639.34 | 7,463 | 7,005 |
Minority Interest in Earnings | -41.1 | -26.21 | -5.07 | -10.27 | -33.4 | 2.54 |
Net Income | 1,702 | 1,465 | 383 | 629.07 | 7,430 | 7,007 |
Net Income to Common | 1,702 | 1,465 | 383 | 629.07 | 7,430 | 7,007 |
Net Income Growth | 130.18% | 282.63% | -39.12% | -91.53% | 6.04% | 3829.56% |
Shares Outstanding (Basic) | 636 | 648 | 660 | 662 | 656 | 574 |
Shares Outstanding (Diluted) | 636 | 648 | 660 | 662 | 675 | 620 |
Shares Change (YoY) | -2.99% | -1.80% | -0.28% | -1.97% | 9.01% | 13.91% |
EPS (Basic) | 2.68 | 2.26 | 0.58 | 0.95 | 11.33 | 12.21 |
EPS (Diluted) | 2.68 | 2.26 | 0.58 | 0.95 | 11.00 | 11.31 |
EPS Growth | 137.27% | 289.65% | -38.95% | -91.36% | -2.73% | 3349.76% |
Free Cash Flow | -1,023 | -710.37 | -936.28 | -649.76 | 3,236 | 5,690 |
Free Cash Flow Per Share | -1.61 | -1.10 | -1.42 | -0.98 | 4.79 | 9.18 |
Dividend Per Share | 0.150 | 0.150 | 0.080 | 0.099 | 0.625 | 1.852 |
Dividend Growth | 15.38% | 87.50% | -19.00% | -84.20% | -66.25% | 3236.76% |
Gross Margin | 23.79% | 22.85% | 13.62% | 12.67% | 61.41% | 68.98% |
Operating Margin | 9.17% | 9.30% | -2.35% | -1.06% | 52.85% | 62.28% |
Profit Margin | 17.28% | 15.39% | 5.54% | 9.51% | 45.75% | 50.64% |
Free Cash Flow Margin | -10.38% | -7.46% | -13.53% | -9.82% | 19.93% | 41.12% |
EBITDA | 1,859 | 1,740 | 557.08 | 556.79 | 8,950 | 8,758 |
EBITDA Margin | 18.88% | 18.27% | 8.05% | 8.42% | 55.11% | 63.29% |
D&A For EBITDA | 956.02 | 854.69 | 719.57 | 627.08 | 367.24 | 140.02 |
EBIT | 903.34 | 885.29 | -162.49 | -70.28 | 8,583 | 8,618 |
EBIT Margin | 9.17% | 9.30% | -2.35% | -1.06% | 52.85% | 62.28% |
Effective Tax Rate | 7.73% | 7.29% | 12.37% | 9.24% | 13.70% | 16.08% |
Revenue as Reported | 9,850 | 9,523 | 6,919 | 6,614 | 16,240 | 13,837 |
Advertising Expenses | - | 18.92 | 32.98 | 17.85 | 91.6 | 54.34 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.